FGF2 and Alzheimer disease: Our results in Table 2 and Supplementary Fig (S2 Fig) indicate that, compared to GAGs from control individuals, GAGs from AD shows decreased capacities to bind to FGF-1 (p = 0.0087), FGF-2 (p = 0.0014) and VEGF165 (p = 0.0051).